All News

Found 104 articles

• Ipsen Appoints Dr. Alexandre Lebeaut As Executive Vice-President, R&D, And Chief Scientific Officer

  4/14/2017

• Ligand Enters Commercial License And Supply Agreements With Marinus Pharma For Captisol-Enabled Ganaxolone

  4/5/2017

• Novartis AG's Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec

  4/3/2017

• Novartis AG Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug

  3/30/2017

• Ligand Announces Licensing Partner Janssen Pharmaceutical Has Filed An IND For An Antibody Discovered Using The OmniAb Technology

  3/28/2017

• Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year

  3/3/2017

• Ligand Expands License With Sermonix To Include Worldwide Rights For Oral Lasofoxifene

  3/1/2017

• Why This Big Biotech Could be Biogen's Downfall

  2/3/2017

• Ophthotech Clinical Disaster Spurs Massive Layoffs

  12/27/2016

• A Look Into Mysterious Moderna's Amazing But Still Untested Technology

  12/15/2016

• Novartis AG’ CAR-T Drug Sends 82% of Patients’ Blood Cancer into Remission, Eyes 2017 for Marketing

  12/6/2016

• Novartis AG and Google’s Verily Miss Smart Contact Lens Human Trial Goal

  11/22/2016

• This is Why Novartis AG Folded Its CAR-T Unit

  10/27/2016

• Novartis AG Shakes it Up Again, Moving Singapore Facility to the Bay Area and Will Create New R&D Ops in Massachusetts and Basel

  10/6/2016

• These are the Days of Moderna's Lives: Behind the Curtain of One of the Most Mysterious Biotechs

  9/14/2016

• Ligand Acquires Portfolio Of Synthetic Royalty And Milestone Rights From Cormatrix Cardiovascular For $17.5 Million

  5/4/2016

• Sanofi May Move Out of Paris HQ to Save Money

  3/22/2016

• Sanofi Poaches New CMO from Novartis AG

  3/11/2016

• GlaxoSmithKline CEO Might Consider Breakup After Novartis AG Deal Completion

  1/14/2016

• What You Need to Know About Checkmate

  12/2/2015